drugset / Trial / NCT05474937

Inhalation of Sevoflurane Versus Intravenous Midazolam,Ketamine,Propofol For Pediatrics Undergoing Upper GI Endoscopy

NCT05474937 ↗

Unknown 74 enrolled Zagazig University
RandomizedParallel-groupOpen-labelSupportive care

Summary

In the field of pediatric gastroenterology, upper gastrointestinal endoscopy has established itself as a diagnostic and therapeutic tool. In order to increase patient tolerance during this procedure, deep sedation is essential. Children are at a higher risk of serious adverse effects from procedural sedation; thus, their safety is a primary issue throughout this procedure. Multiple studies have been done to find the ideal method for procedural sedation in terms of ease of administration, quality, safety of sedation and recovery profile, but the consensus seems lacking. In this study we will compare between nasal inhalation of sevoflurane versus intravenous ketamine, midazolam and propofol for pediatrics undergoing upper gastrointestinal endoscopy.

Timeline

Start
2022-06-01
Primary completion
2022-11-30
Completion
2022-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 1 mg/kg Intravenous
Comparator Ketamine Small molecule 1.5 mg/kg Intravenous
Comparator Midazolam Small molecule 0.05 mg/kg Intravenous
Comparator Propofol Small molecule 100 ug/kg Intravenous
Comparator Propofol Small molecule 0.5 mg/kg Intravenous
Comparator Sevoflurane Other / unclassified 7 % Inhaled

Indications

No indication recorded.